| For: | El-Zayadi AR, Anis M. Hepatitis C virus induced insulin resistance impairs response to anti viral therapy. World J Gastroenterol 2012; 18(3): 212-224 [PMID: 22294824 DOI: 10.3748/wjg.v18.i3.212] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i3/212.htm |
| Number | Citing Articles |
| 1 |
Xiaoli Zhong, Waseem Abbas, Farman Ullah, Rafi Ullah. Hepatitis C Virus Infection Induces Autoimmune Hypothyroidism with Potential Profound Metabolic Implications: A Cross-Sectional Study in a High-Prevalence Region. Metabolites 2026; 16(2) doi: 10.3390/metabo16020104
|
| 2 |
Shih-Yi Lin, Cheng-Li Lin, Shu-Woei Ju, I-Kuan Wang, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Ji-An Liang, Tatsuo Kanda. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0173125
|
| 3 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2) doi: 10.1111/apt.15575
|
| 4 |
|
| 5 |
|
| 6 |
Tayebeh Hashempour, Behzad Dehghani, Zahra Musavi, Javad Moayedi, Zahra Hasanshahi, Jamal Sarvari, Seyed Younes Hosseini, Ebrahim Hosseini, Maryam Moeini, Shahin Merat. Impact of IL28 Genotypes and Modeling the Interactions of HCV Core Protein on Treatment of Hepatitis C. Interdisciplinary Sciences: Computational Life Sciences 2020; 12(4) doi: 10.1007/s12539-020-00382-8
|
| 7 |
Rodrigo C. Moreira, Antonio G. Pacheco, Adelzon Paula, Sandra W. Cardoso, Ronaldo I. Moreira, Sayonara R. Ribeiro, Estevão P. Nunes, Maria R. Guimarães, Fernanda C. Mello, Valdilea G. Veloso, Beatriz Grinsztejn. Diabetes Mellitus is Associated with Increased Death Rates Among HIV-Infected Patients in Rio de Janeiro, Brazil. AIDS Research and Human Retroviruses 2016; 32(12) doi: 10.1089/aid.2015.0265
|
| 8 |
Danielle Gonçalves, Claudia Lima, Paula Ferreira, Paulo Costa, Angela Costa, Walter Figueiredo, Thais Cesar. Orange juice as dietary source of antioxidants for patients with hepatitis C under antiviral therapy. Food & Nutrition Research 2017; 61(1) doi: 10.1080/16546628.2017.1296675
|
| 9 |
Nourhan M. El Samaloty, Zeinab A. Hassan, Zeinab M. Hefny, Dalia H.A. Abdelaziz. Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients. Arab Journal of Gastroenterology 2019; 20(1) doi: 10.1016/j.ajg.2019.01.011
|
| 10 |
Vasiliki Katsi, Ioannis Felekos, Stamatios Skevofilax, Constantina Aggeli, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros. Cardiovascular Disease and Hepatitis C Virus Infection. Cardiology in Review 2015; 23(1) doi: 10.1097/CRD.0000000000000031
|
| 11 |
Samia T. Ali, Nagwa A. Mohamed. Inadequate serum hepcidin levels in chronic hepatitis C infection-induced type 2 diabetes mellitus. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(1) doi: 10.4103/sjamf.sjamf_59_18
|
| 12 |
Jing‑Hong Hu, Ming‑Ling Chang, Nai‑Jen Liu, Chu‑Ting Yeh, Tung‑Jung Huang. Effect of HCV treatment response on insulin resistance: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7995
|
| 13 |
Jonathan G. Stine, Javelle A. Wynter, Blake Niccum, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C. Annals of Hepatology 2017; 16(2) doi: 10.5604/16652681.1231581
|
| 14 |
Yang Ji, Yingmin Liang, Judith C.W. Mak, Mary S.M. Ip. Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease. Sleep Medicine 2022; 95 doi: 10.1016/j.sleep.2022.04.006
|
| 15 |
Sundararajan Mahalingam, Kusum K. Kharbanda, Carol A. Casey, Karuna Rasineni. Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1752204
|
| 16 |
Alexander Plakida, Olga Iushkovska, Lidia Elżbieta Sierpińska. Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease. World Journal of Hepatology 2026; 18(3): 113284 doi: 10.4254/wjh.v18.i3.113284
|
| 17 |
Maher BM. Boraie, Yasser A. Elnaggar, Mohammed Othman Ahmed, Ahmed M. Mahmoud. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4) doi: 10.1016/j.dsx.2019.07.032
|
| 18 |
Ammon Handisurya, Corinna Kerscher, Andrea Tura, Harald Herkner, Berit Anna Payer, Mattias Mandorfer, Johannes Werzowa, Wolfgang Winnicki, Thomas Reiberger, Alexandra Kautzky-Willer, Giovanni Pacini, Marcus Säemann, Alice Schmidt, Jose Ignacio Herrero. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. PLOS ONE 2016; 11(1) doi: 10.1371/journal.pone.0145319
|
| 19 |
Chul Soo Park. Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation. World Journal of Gastroenterology 2015; 21(22): 6835-6841 doi: 10.3748/wjg.v21.i22.6835
|
| 20 |
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ali M. Bazzi, Wadha A. Alfouzan, Shahab A. Alsuliman, Fatimah A. Aldrazi, Shafiul Haque. Overview of hepatitis C infection, molecular biology, and new treatment. Journal of Infection and Public Health 2020; 13(5) doi: 10.1016/j.jiph.2019.11.015
|
| 21 |
Emanuelle V. de Lima, Clara O. Nogueira, Raissa R. Christoff, Emylle Costa-Bartuli, Tathiany Igreja-Silva, Mariana Oliveira Lopes da Silva, Daniel Gavino-Leopoldino, Maria Luiza Móra Santos, Felipe Simões Lemos, Jaderson C. da Costa, Gianina T. Venturin, Iranaia Assunção-Miranda, João M. N. Duarte, Claudia P. Figueiredo, Giselle F. Passos, Julia R. Clarke. Central Zika virus infection causes hypothalamic inflammation and persistent insulin resistance in adult mice. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-08046-5
|
| 22 |
Yuchang Li, Liting Chen, Vassilios Papadopoulos. The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases. Biochimie 2024; 224 doi: 10.1016/j.biochi.2023.11.013
|
| 23 |
Gaurav Kumar Chaubey, Rahul Dilawari, Radheshyam Modanwal, Sharmila Talukdar, Asmita Dhiman, Manoj Raje. Metformin in COVID-19: a magical role beyond the hyperglycemia. Exploration of Drug Science 2024; doi: 10.37349/eds.2024.00055
|
| 24 |
Suhag Patel, Raxitkumar Jinjuvadia, Ravi Patel, Suthat Liangpunsakul. Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients. Journal of Clinical Gastroenterology 2016; 50(1) doi: 10.1097/MCG.0000000000000400
|
| 25 |
Yaru Zhou, Wenyue Wu, Zhifang Xu, Yan Liu, Hengrui Chang, Peng Yu, Xiaojuan Zhang, Yu Yang, Kuanzhi Liu, Yanzhong Chang. Iron regulatory protein 2 deficiency may correlate with insulin resistance. Biochemical and Biophysical Research Communications 2019; 510(2) doi: 10.1016/j.bbrc.2019.01.022
|
| 26 |
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020; 38(1) doi: 10.2337/cd18-0112
|
| 27 |
Sahar A. Ali, Walaa M.H. Nassif, Dalia H.A. Abdelaziz. Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study. Clinics and Research in Hepatology and Gastroenterology 2016; 40(4) doi: 10.1016/j.clinre.2015.12.003
|
| 28 |
Kamila Wójcik, Anna Piekarska, Alina Dąbrowicz, Marta Stasiak, Katarzyna Gawryś, Elżbieta Jabłonowska. Hepatic Expression of Phosphorylated Kinase Akt and Glycogen Synthase Kinase-3 Isoforms in Patients with Chronic Hepatitis C. Viral Immunology 2019; 32(4) doi: 10.1089/vim.2018.0141
|
| 29 |
Shen‐Shong Chang, Ching‐Hsuan Liu, Shu‐Yen Chan, Liang‐Tzung Lin. Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post‐DAA Management. Journal of Medical Virology 2026; 98(5) doi: 10.1002/jmv.70952
|
| 30 |
T. O. Freire, R. S. S. B. Boulhosa, L. P. M. Oliveira, R. P. de Jesus, L. N. Cavalcante, D. C. Lemaire, M. B. P. Toralles, L. G. C. Lyra, A. C. Lyra. n‐3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial. Journal of Human Nutrition and Dietetics 2016; 29(3) doi: 10.1111/jhn.12327
|
| 31 |
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis C. Acta Tropica 2018; 178 doi: 10.1016/j.actatropica.2017.12.004
|
| 32 |
Carla Krueger, Mark Collister, Gerald Y. Minuk, Alyssa Janke, Jordyn Lerner, Stephen G. M. Wong, Julia D. Rempel. HCV protein‐induced cytokine predicts treatment outcomes in chronic hepatitis C virus infection. Liver International 2014; 34(6) doi: 10.1111/liv.12418
|
| 33 |
Brenda Y. Hernandez, Xuemei Zhu, Sandi Kwee, Owen T.M. Chan, Naoky Tsai, Gordon Okimoto, David Horio, Katherine A. McGlynn, Sean Altekruse, Linda L. Wong. Viral Hepatitis Markers in Liver Tissue in Relation to Serostatus in Hepatocellular Carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(11) doi: 10.1158/1055-9965.EPI-13-0397
|
| 34 |
Kamila Wójcik, Elżbieta Jabłonowska, Aleksandra Omulecka, Anna Piekarska. Insulin resistance, adipokine profile and hepatic expression of <italic>SOCS-3</italic> gene in chronic hepatitis C. World Journal of Gastroenterology 2014; 20(30): 10449-10456 doi: 10.3748/wjg.v20.i30.10449
|
| 35 |
Ming-Lun Han, Wei-Jei Lee, Jung-Chien Chen, Kong-Han Ser, Shu-Chun Chen, Yi-Chih Lee. Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection. Obesity Surgery 2019; 29(3) doi: 10.1007/s11695-018-3615-z
|
| 36 |
Sonia Samuel, Ahmad Abulawi, Raza Malik. Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation. Gastroenterology Insights 2023; 14(3) doi: 10.3390/gastroent14030018
|
| 37 |
Ahmed S. Yousef, Alaliaa M. Sallam, Nahla S. kotb, Hala O. El-Mesallamy. The association of Fat Mass and Obesity-Associated (FTO) gene polymorphism (rs9939609) with metabolic disturbances and response to sofosbuvir, ribavirin and interferon triple therapy in patients with viral hepatitis C. Meta Gene 2021; 28 doi: 10.1016/j.mgene.2021.100888
|
| 38 |
Engy Yousry Elsayed, Nesreen Ahmed Mosalam, Noha Refaat Mohamed. Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis. Asian Pacific Journal of Cancer Prevention 2015; 16(16) doi: 10.7314/APJCP.2015.16.16.7139
|
| 39 |
Nadhya Allia, Poernomo Boedi Setiawan, Soebagijo Adi Soelistijo. CORRELATION BETWEEN HCV RNA VIRAL LOAD AND HOMA-IR IN CHRONIC HEPATITIS C PATIENTS. Current Internal Medicine Research and Practice Surabaya Journal 2021; 2(2) doi: 10.20473/cimrj.v2i2.26537
|
| 40 |
A.M. Duca, S. de la Fuente, M.J. Citores, A.B. Cuenca, E. Cisneros, N. Escamilla, I. Baños, C. Vilches, V. Cuervas-Mons. CC Genotype at rs12979860 of IL28B Is Associated With Lower Risk of New-onset Diabetes After Transplantation in Adult Patients With Liver Transplantation for Hepatitis C Cirrhosis. Transplantation Proceedings 2014; 46(9) doi: 10.1016/j.transproceed.2014.10.004
|
| 41 |
Marina Angel, Yelena Petrosyan, Mary-Anne Doyle, Curtis Cooper. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01198-x
|
| 42 |
K. Gouthamchandra, Anuj Kumar, Shivaprasad Shwetha, Anirban Mukherjee, Madhavi Chandra, B. Ravishankar, M. N. Khaja, Provash Chandra Sadhukhan, Saumitra Das. Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator.
Journal of General Virology
2014; 95(8) doi: 10.1099/vir.0.062430-0
|
| 43 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Resistencia a la insulina en pacientes egipcios no diabéticos infectados con el virus de hepatitis C crónica. Revista de Gastroenterología de México 2020; 85(2) doi: 10.1016/j.rgmx.2019.05.005
|
| 44 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus. Revista de Gastroenterología de México (English Edition) 2020; 85(2) doi: 10.1016/j.rgmxen.2019.05.007
|
| 45 |
Mohamed Sayed Hassan, Yousra Hamed Mourad, Mohammad Ahmad Elghobary. Diabetogenic effect of hepatitis C virus and insulin resistance among chronic hepatitis C patients. The Egyptian Journal of Internal Medicine 2016; 28(4) doi: 10.4103/1110-7782.203294
|
| 46 |
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function Testing. Pathophysiology 2022; 29(3) doi: 10.3390/pathophysiology29030024
|